The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.

Addendum to ICH M7: Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk - Application of the Principles of the ICH M7 Guideline to Calculation of Compound-Specific Acceptable Intakes

Short Title:
ICH M7(R1)

This guideline provides useful information regarding the acceptable limits of known mutagenic impurities.

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information